Alvaro G. Alvarado
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alvaro G. Alvarado has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Harley I. Kornblum
Department of Psychiatry and Human Behavior, University of California, Los Angeles , Los Angeles, CA 90095
57 shared publications - Sree Deepthi Muthukrishnan
Department of Oncology Science, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
55 shared publications - Albert Lai
Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles , Los Angeles, CA
31 shared publications - Amy Pham
Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, California
31 shared publications - David Wang
Department of Surgery, School of Medicine, University of California, Davis, Sacramento, CA
31 shared publications - Fuying Gao
Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, California
31 shared publications
Latest Publications
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
Supplementary Figure S5. ASPN expression is enriched in IDH mutant LGG and regulated by D-2HG
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
Supplementary Figure S5. ASPN expression is enriched in IDH mutant LGG and regulated by D-2HG
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
Supplementary Table S6 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
Supplementary Table S6 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Data from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
A key feature distinguishing high-grade glioma (HG) from low-grade glioma (LG) is the extensive neovascularization and endothelial hyperproliferation. Prior work has shown that tumor-associated vasculature from HG is molecularly and functionally distinct from normal brain vasculature and expresses higher levels of protumorigenic factors that promote glioma growth and progression. However, it remains unclear whether vessels from LG also express protumorigenic factors, and to what extent they functionally contribute to glioma growth. Here, we profile the transcriptomes of glioma-associated vascular cells (GVC) from IDH-mutant (mIDH) LG and IDH-wild-type (wIDH) HG and show that they exhibit significant molecular and functional differences. LG-GVC show enrichment of extracellular matrix–related gene sets and sensitivity to antiangiogenic drugs, whereas HG-GVC display an increase in immune response–related gene sets and antiangiogenic resistance. Strikingly, conditioned media from LG-GVC inhibits the growth of wIDH glioblastoma cells, whereas HG-GVC promotes growth. In vivo cotransplantation of LG-GVC with tumor cells reduces growth, whereas HG-GVC enhances tumor growth in orthotopic xenografts. We identify ASPORIN (ASPN), a small leucine-rich repeat proteoglycan, highly enriched in LG-GVC as a growth suppressor of wIDH glioblastoma cells in vitro and in vivo. Together, these findings indicate that GVC from LG and HG are molecularly and functionally distinct and differentially regulate tumor growth.Implications: This study demonstrated that vascular cells from IDH-mutant LG and IDH-wild-type HG exhibit distinct molecular signatures and have differential effects on tumor growth via regulation of ASPN-TGFβ1-GPM6A signaling.
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
A key feature distinguishing high-grade glioma (HG) from low-grade glioma (LG) is the extensive neovascularization and endothelial hyperproliferation. Prior work has shown that tumor-associated vasculature from HG is molecularly and functionally distinct from normal brain vasculature and expresses higher levels of protumorigenic factors that promote glioma growth and progression. However, it remains unclear whether vessels from LG also express protumorigenic factors, and to what extent they functionally contribute to glioma growth. Here, we profile the transcriptomes of glioma-associated vascular cells (GVC) from IDH-mutant (mIDH) LG and IDH-wild-type (wIDH) HG and show that they exhibit significant molecular and functional differences. LG-GVC show enrichment of extracellular matrix–related gene sets and sensitivity to antiangiogenic drugs, whereas HG-GVC display an increase in immune response–related gene sets and antiangiogenic resistance. Strikingly, conditioned media from LG-GVC inhibits the growth of wIDH glioblastoma cells, whereas HG-GVC promotes growth. In vivo cotransplantation of LG-GVC with tumor cells reduces growth, whereas HG-GVC enhances tumor growth in orthotopic xenografts. We identify ASPORIN (ASPN), a small leucine-rich repeat proteoglycan, highly enriched in LG-GVC as a growth suppressor of wIDH glioblastoma cells in vitro and in vivo. Together, these findings indicate that GVC from LG and HG are molecularly and functionally distinct and differentially regulate tumor growth.Implications: This study demonstrated that vascular cells from IDH-mutant LG and IDH-wild-type HG exhibit distinct molecular signatures and have differential effects on tumor growth via regulation of ASPN-TGFβ1-GPM6A signaling.
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
Supplementary Figure S2. Molecular and functional differences between LG- and HG-GVC
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
Supplementary Figure S2. Molecular and functional differences between LG- and HG-GVC
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
Supplementary Table S6 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
Supplementary Table S6 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
Supplementary Figure S1. Characterization of cultured GVC
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
Supplementary Figure S1. Characterization of cultured GVC
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
Supplementary Figure S7. ASPN inhibits wIDH GBM growth via modulation of TGFΒ1-GPM6A signaling
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
Supplementary Figure S7. ASPN inhibits wIDH GBM growth via modulation of TGFΒ1-GPM6A signaling
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
Supplementary Figure S6. ASPN knockdown and validation in cultured GVC
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
Supplementary Figure S6. ASPN knockdown and validation in cultured GVC
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
Downregulated canonical pathways in LG-, PRI- and REC-GVC
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth
Downregulated canonical pathways in LG-, PRI- and REC-GVC